Future Infectious Disease Nucleic Acid Testing

Published by: Venture Planning Group

Published: Feb. 14, 2012 - 360 Pages


Table of Contents


1. Overview

2. Major Infectious Diseases

* AIDS

O Structure and Composition

O Classification

O AIDS Origins

O Animal Lentivirus Systems

O Virus Receptors

O HIV Infections in Humans

- Pathogenesis and Pathology

O CD4T Lymphocytes and Memory Cells

O Monocytes and Macrophages

O Lymphoid Organs

O Neural Cells

O Viral Coinfections

- Clinical Findings

O Plasma Viral Load

O Pediatric AIDS

- Neurologic Disease

- Opportunistic Infections

- Cancer

O Immunity

- Virus Isolation

- Serology

- Viral Nucleic Acid/Antigen Detection

O Epidemiology

- Worldwide Spread of AIDS

- United States

- Routes of Transmission

O DNA Probes

- Overview

- Quantitative PCR

- In Situ PCR

- Needed Improvements

O Viral Load/Drug Resistance Testing

O Genotype and Phenotype Testing

O Blood Banking Considerations

* Adenovirus

O Background

O Diagnostic Tests

O Vaccines and Drugs

O Adeno-Associated Viruses (AAV)

* Anthrax/Bacillus Anthracis

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Babesiosis

O Background

* BEA and Other Bartonella Diseases

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Chagas Disease

O Background

* Campylobacter

O Background

O Diagnostic Tests

- Culture Identification

O Vaccines and Drugs

* Chlamydia

O Background

- Chlamydia psittaci

- Chlmaydia pneumoniae

- Chlamydia trachomatis

O Diagnostic Tests

O Vaccines and Drugs

* Creutzfeldt-Jakob’s Disease

O Background

O Blood Transmission

O Diagnostic Tests

O Major Commercial and Academic Players

- Bayer

- Disease Sciences/Bio Tec Global

- Imperial College School of Medicine

- Ortho-Clinical Diagnostics

- Pall

- ProMetic Life Sciences

- Proteome Sciences/Idexx

- Q-One Biotech

- Serono

- U.S. Agricultural Research Service

O Drugs

O Vaccines

* Cytomegalovirus

O Background

- Chorioretinitis

- Gastrointestinal

- Central Nervous System Disease

O Diagnostic Tests

O Vaccines and Drugs

* Ebola Virus

O Background

- Epidemiology

- Clinical Syndromes

O Diagnostic Tests

O Vaccines and Drugs

* EchoVirus

O Background

- Acute Aseptic Meningitisis

- Encephalitis

- Exanthems

- Respiratory Disease

- Myopericarditis

- Neonatal Infections

O Diagnostic Tests

O Vaccines and Drugs

* Encephalitis

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Enteroviruses

O Background

O Diagnostic Tests

- Viral Isolation and Identification

- Antibody Tests

O Vaccines and Drugs

* Epstein-Barr Virus

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Gonorrhea

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Hepatitis

O Hepatitis A

O Hepatitis B

- Structure and Composition

- Replication

O Hepatitis C

O Hepatitis D (Delta)

O Hepatitis E

O Hepatitis G

O Hepatitis Infections Pathology

O Clinical Findings

O Laboratory Tests

- Hepatitis A

- Hepatitis B

- Hepatitis C

- Hepatitis D

- Hepatitis E

O Virus-Host Immune Reactions

O Epidemiology

- Hepatitis A

- Hepatitis B

- Hepatitis C

- Hepatitis D (Delta)

O Vaccines and Drugs

* Herpes Simplex Virus

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Legionella

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Lyme Disease

O Background

- Clinical Description

- Clinical Case Definition

- Laboratory Criteria for Diagnosis

- Case Classification

O Diagnostic Tests

O Vaccines and Drugs

* Malaria

* Mycoplasma

O Background

- Ureaplasma Urealyticum & Mycoplasma Hominis

O Diagnostic Tests

O Vaccines and Drugs

* Papillomaviruses/HPV

O Background

- HPV in Cancer

- Cervical Neoplasm

O Diagnostic Tests

O Vaccines and Drugs

- Prevention

* Parvovirus B19

O Background

- Microbiology

- Epidemiology

- Clinical Syndromes

- Erythema Infectiosum (Slapped Cheek)

- Adult Polyarthropathy

- Transient Aplastic Crisis

- Transient Pancytopenia

- Red Cell Aplasia in Immunocompromised

- Perinatal Infections

O Diagnostic Test

O Vaccines and Drugs

* Pneumonia

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Polyomaviruses

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Salmonellosis

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Shigellosis

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Streptococci

O Background

O Diagnostic Tests

O Vaccines and Drugs

- Group A Streptococci

- Group B Streptococci

* Toxoplasmosis

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Tuberculosis

O Background

O Diagnostic Tests

- Microscopic Characteristics

- Cultural Characteristics

- Skin Tests

- MDRTB

O Vaccines and Drugs

* West Nile Virus

O Background

- Clinical Syndromes

O Diagnostic Tests

O Vaccines and Drugs

* Yersinia

O Background

O Diagnostic Tests

O Vaccines and Drugs

3. Antibiotic Susceptibility

List of Tables

Table 1: Major Companies Developing or MarketingAIDS NAT and other DirectIdentification Tests

Table 2: Major Companies Developing or MarketingAdenovirus NAT and otherDirect Identification Tests

Table 3: Major Companies Developing or MarketingCampylobacter NAT andOther Direct Identification Tests

Table 4: Major Companies Developing or MarketingChlamydia NAT and otherDirect Identification Tests

Table 5: Major Companies Developing or MarketingCMV NAT and other DirectIdentification Tests

Table 6: Major Companies Developing or MarketingEBV NAT and other DirectIdentification Tests

Table 7: Major Companies Developing or MarketingGonorrhea NAT and otherDirect Identification Tests

Table 8: Major Companies Developing or MarketingHepatitis NAT and otherDirect Identification Tests

Table 9: Major Companies Developing or MarketingHerpes NAT and otherDirect Identification Tests

Table 10: Major Companies Developing or MarketingLegionella NAT and otherDirect Identification Tests

Table 11: Major Companies Developing or MarketingLyme Disease NATAnd Other Direct Identification Tests

Table 12: Major Companies Developing or MarketingMycoplasma NATAnd other Direct Identification Tests

Table 13: Major Companies Developing or MarketingPapilloma Virus NATAnd Other Direct Identification Tests

Table 14: Major Companies Developing or MarketingPneumonia NATAnd other Direct Identification Tests

Table 15: Major Companies Developing or MarketingSalmonella NATAnd other Direct Identification Tests

Table 16: Major Companies Developing or MarketingShigella NATAnd other Direct Identification Tests

Table 17: Major Companies Developing or MarketingStreptococci NATAnd Other Direct Identification Tests

Table 18: Major Companies Developing or MarketingToxoplasmosis NATAnd Other Direct Identification Tests

Table 19: Major Companies Developing or MarketingTuberculosis NATAnd Other Direct Identification Tests

Abstract

This 360-page report presents an overview of the clinical significance and market needs for major infectious diseases, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products.

Contains 360 pages and 20 tables

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.

Get full details about this report >>
 
Learn more about this product


Price and delivery options
See related reports or call the number below for help from a research specialist.

US: 800.298.5699

Int'l: +1.240.747.3093

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.